Deepti Anbarasan, MD.
Dr. Anbarasan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Adherence may often limit effectiveness of medications for opioid use disorder among youth. In this randomized controlled trial, young adults with opioid use disorder were randomized to either youth opioid recovery support (an assertive intervention designed to increase adherence) or treatment as usual, both involving extended-release naltrexone.
In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available...